Evaluations of nephro-protective activity of poly-herbal hydroalcoholic extract against streptozotocin-induced nephrotoxicity and renal dysfunction
DOI:
https://doi.org/10.47552/ijam.v15i4.4489Keywords:
Streptozotocin, Diabetic Nephropathy, Solanum xanthocarpumAbstract
Objective our research work aim was the assessment of the nephroprotective activity of poly-herbal hydroalcoholic extract against streptozotocin-induced nephrotoxicity and renal dysfunction. Poly-herbal hydroalcoholic extract of (PHHE) nephrotoxicity activity was determined using the streptozotocin-induced nephrotoxicity and renal dysfunction method. Poly-herbal hydroalcoholic extract of 200 and 300 mg/kg was given for eight weeks to selected animals rat models. The biochemical parameters like as lipid profile, renal functional, antioxidant enzyme level, anti-inflammatory factors and histopathological evaluations parameters were used for estimation of nephroprotective activity. PHHE also reduced the levels of creatinine, blood urea nitrogen, total cholesterol, triglycerides, advanced glycation end products and albumin in serum and urine, respectively. PHHE drastically increased the antioxidant parameters in the kidney and histological evaluation. All of these evaluations parameters results were exposed that PHEE has potential antioxidant, and anti-glycation activities. Exhibited significant therapeutic effects and was found to be the potential same as standard glimepiride drug. The experimental results were found to be significant nephroprotective action of PHHE extract on STZ induced diabetic nephroprotective animal model. Conclude the PHHE can use for the treatment and management of diabetic nephropathy disease.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 International Journal of Ayurvedic Medicine
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.
This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.
The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.